Generation and evaluation of bispecific affibody molecules for simultaneous targeting of EGFR and HER2

Bioconjugate Chemistry

Volumn 23, Issue 9, 2012, Pages 1802-1811

  Ekerljung, Lina ^a   Wällberg, Helena ^b   Sohrabian, Azita ^a   Andersson, Karl ^a,c   Friedman, Mikaela ^a   Frejd, Fredrik Y ^a,d   Stähl, Stefan ^b   Gedda, Lars ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^c Ridgeview Instruments AB   (Sweden)

^d Affibody AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOLOGY; DIAGNOSIS; DIMERS; IONIZING RADIATION; MOLECULES; PROTEINS; RADIATION EFFECTS;

AFFIBODY MOLECULES; CELL-BINDING; CO-EXPRESSION; EPIDERMAL GROWTH FACTOR RECEPTORS; HUMAN EPIDERMAL GROWTH FACTOR; MONOMERICS; PATIENT PROGNOSIS; PEPTIDE LINKERS; SPECIFIC BINDING; SURFACE RECEPTORS;

CELLS;

BISPECIFIC AFFIBODY MOLECULE; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PEPTIDES AND PROTEINS; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING ASSAY; CARBOXY TERMINAL SEQUENCE; CELL INTERACTION; CONTROLLED STUDY; DIMERIZATION; HUMAN; HUMAN CELL; NONHUMAN;

EID: 84866357369     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc3000645     Document Type: Article

References (25)

1. Chen, J. S., Lan, K., and Hung, M. C. (2003) Strategies to target HER2/neu overexpression for cancer therapy Drug Resistance Updates 6, 129-136 (Pubitemid 36890337)
2. Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., and McGuire, W. L. (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene Science 235, 177-82 (Pubitemid 17231334)
3. Marmor, M. D., Skaria, K. B., and Yarden, Y. (2004) Signal transduction and oncogenesis by ErbB/HER receptors Int. J. Radiat. Oncol. Biol. Phys. 58, 903-913 (Pubitemid 38221150)
4. Graus-Porta, D., Beerli, R. R., Daly, J. M., and Hynes, N. E. (1997) ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling EMBO J. 16, 1647-55 (Pubitemid 27151960)
5. Franklin, M. C., Carey, K. D., Vajdos, F. F., Leahy, D. J., de Vos, A. M., and Sliwkowski, M. X. (2004) Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex Cancer Cell 5, 317-328 (Pubitemid 38482068)
6. Garrett, T. P. J., McKern, N. M., Lou, M., Elleman, T. C., Adams, T. E., Lovrecz, G. O., Zhu, H.-J., Walker, F., Frenkel, M. J., Hoyne, P. A., Jorissen, R. N., Nice, E. C., Burgess, A. W., and Ward, C. W. (2002) Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor ± Cell 110, 763-773 (Pubitemid 35283965)
7. Hirsch, F. R., Varella-Garcia, M., and Cappuzzo, F. (2009) Predictive value of EGFR and HER2 overexpression in advanced non-small-cell lung cancer Oncogene 28, S32-S37
8. Tsutsui, S., Ohno, S., Murakami, S., Kataoka, A., Kinoshita, J., and Hachitanda, Y. (2003) Prognostic value of the combination of epidermal growth factor receptor and c-erbB-2 in breast cancer Surgery 133, 219-221 (Pubitemid 36407987)
9. Friedman, M., Lindström, S., Ekerljung, L., Andersson-Svahn, H., Carlsson, J., Brismar, H., Gedda, L., Frejd, F. Y., and Stähl, S. (2009) Engineering and characterization of a bispecific HER2 - EGFR-binding affibody molecule Biotechnol. Appl. Biochem. 54, 121-131
10. Rüther, U. (1982) pUR 250 allows rapid chemical sequencing of both DNA strands of its inserts Nucleic Acids Res. 10, 5765-5772
11. Studier, W. F., Rosenberg, A. H., Dunn, J. J., and Dubendorff, J. W. (1990) Use of T7 RNA polymerase to direct expression of cloned genes, in Methods Enzymol. (David, V. G., Ed.) pp 60-89, Academic Press. (Pubitemid 20219811)
12. Friedman, M., Orlova, A., Johansson, E., Eriksson, T. L. J., Höidén-Guthenberg, I., Tolmachev, V., Nilsson, F. Y., and Stähl, S. (2008) Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody molecule J. Mol. Biol. 376, 1388-1402
13. Wikman, M., Steffen, A. C., Gunneriusson, E., Tolmachev, V., Adams, G. P., Carlsson, J., and Stähl, S. (2004) Selection and characterization of HER2/neu-binding affibody ligands Protein Eng., Des. Sel. 17, 455-462 (Pubitemid 39294720)
14. Orlova, A., Magnusson, M., Eriksson, T. L. J., Nilsson, M., Larsson, B., Höiden-Guthenberg, I., Widström, C., Carlsson, J., Tolmachev, V., Stähl, S., and Nilsson, F. Y. (2006) Tumor imaging using a picomolar affinity HER2 binding Affibody molecule Cancer Res. 66, 4339-4348
15. 125I-EGF PLoS ONE 6, e24739
16. Schoeberl, B., Faber, A. C., Li, D., Liang, M. C., Crosby, K., Onsum, M., Burenkova, O., Pace, E., Walton, Z., Nie, L., Fulgham, A., Song, Y., Nielsen, U. B., Engelman, J. A., and Wong, K. K. (2010) An ErbB3 antibody, MM-121, is active in cancers with ligand-dependent activation Cancer Res. 70, 2485-2494
17. Björke, H. and Andersson, K. (2006) Measuring the affinity of a radioligand with its receptor using a rotating cell dish with in situ reference area Appl. Radiat. Isotopes 64, 32-37 (Pubitemid 41550168)
18. 177Lu-labeled antibodies binding to CD44v6 using a novel automated radioimmunoassay J. Mol. Recognit. 21, 179-183 (Pubitemid 351821990)
19. Barta, P., Malmberg, J., Melicharova, L., Strandgard, J., Orlova, A., Tolmachev, V., Laznicek, M., and Andersson, K. (2012) Protein interactions with HER-family receptors can have different characteristics depending on the hosting cell line Int. J. Oncol. 40, 1677-1682
20. Ekerljung, L., Steffen, A. C., Carlsson, J., and Lennartsson, J. (2006) Effects of HER2-binding affibody molecules on intracellular signaling pathways Tumor Biol. 27, 201-210
21. Penuel, E., Akita, R. W., and Sliwkowski, M. X. (2002) Identification of a region within the ErbB2/HER2 intracellular domain that is necessary for ligand-independent association J. Biol. Chem. 277, 28468-28473 (Pubitemid 41079271)
22. Ignatoski, K. M. W., LaPointe, A. J., Radany, E. H., and Ethier, S. P. (1999) erbB-2 overexpression in human mammary epithelial cells confers growth factor independence Endocrinology 140, 3615-3622 (Pubitemid 30645416)
23. Ekerljung, L., Lindborg, M., Gedda, L., Frejd, F. Y., Carlsson, J., and Lennartsson, J. (2008) Dimeric HER2-specific affibody molecules inhibit proliferation of the SKBR-3 breast cancer cell line Biochem. Biophys. Res. Commun. 377, 489-94
24. Burgess, A. W., Cho, H. S., Eigenbrot, C., Ferguson, K. M., Garrett, T. P. J., Leahy, D. J., Lemmon, M. A., Sliwkowski, M. X., Ward, C. W., and Yokoyama, S. (2003) An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors Mol. Cell 12, 541-552 (Pubitemid 37222478)
25. Nordberg, E., Friedman, M., Gostring, L., Adams, G. P., Brismar, H., Nilsson, F. Y., Stahl, S., Glimelius, B., and Carlsson, J. (2007) Cellular studies of binding, internalization and retention of a radiolabeled EGFR-binding affibody molecule Nucl. Med. Biol. 34, 609-18 (Pubitemid 47248288)